Table 4.
Compound | Concentration Tested | Macroalgae | Bioactivity | Type of Model | Experimental Model | Reference |
---|---|---|---|---|---|---|
Fucoxanthin | 50–200 mg/kg | S. horneri | Inhibition of AChE and animal behaviour | In vitro and in vivo | In vitro AChE inhibition and scopolamine-induced cognitive impairment in ICR mice (parameters assessed: locomotor activity, recognition impairment, spatial learning and memory impairments, expression of neurotropic factors, and ChAT and AChE activity) |
[205] |
Fucoxanthin | 2–100 µM | U. pinnatifida | Inhibition of BACE1 | In vitro | In vitro assay | [208] |
Fucoxanthin | 2–100 µM | E. stolonifera | Inhibition of BACE1 | In vitro | In vitro assay | [208] |
Fucoxanthin | 100–400 µM | E. bicyclis | Inhibition of hMAOs | In vitro | In vitro assay | [211] |
Fucoxanthin | 100–400 µM | U. pinnatifida | Inhibition of hMAOs | In vitro | In vitro assay | [211] |
Extract and fractions containing phycobiliproteins and chlorophyll a | 100–500 µg/mL |
P. palmata | Anti-inflammatory | In vitro | LPS-stimulated RAW 264.7 cells (parameters assessed: Levels of •NO, TNF-α, and IL-6) | [310] |
Ethanol extract, fucoxanthin, and fucoxanthinol | Extract (5–30 µg/mL) Fucoxanthin (25–250 ng/mL) Fucoxanthinol (50–100 ng/mL) |
U. pinnatifida | Antioxidant | In vitro | Primary cultures of rat hippocampal neurons (parameters assessed: cell viability, apoptosis, mitochondrial integrity, intracellular ROS, and total length of primary neurites) | [312] |
Fucoxanthin | 0.1–30 µM (in vitro) 50–200 mg/kg (in vivo) |
S. horneri | Inhibition of Aβ assembly | In vitro and in vivo | In vitro inhibition of Aβ1–42 oligomers formation; SH-SY5Y cells treated with Aβ1–42 oligomers (parameters assessed: cell survival); Aβ1–42 oligomer-treated mice (parameters assessed: locomotor activity, and recognition performance) |
[313] |
Ethyl acetate fraction containing fucoxanthin, canthaxanthin, and violaxanthin, among other compounds | 10–100 µg/mL | E. prolifera | Antioxidant and anti-apoptotic | In vitro | HT-22 cells treated with glutamate (parameters assessed: cell viability, intracellular ROS, apoptosis, expression of antioxidant activities, and neurotropic factors) | [314] |
Fucoxanthin | 0.3–3 µM | S. horneri | Antioxidant and Inhibition of Aβ assembly | In vitro | SH-SY5Y cells treated with Aβ oligomers (parameters assessed: cell viability, apoptosis, intracellular ROS, and activation of signalling pathways) | [343] |
Fucoxanthin | 0.3–3 µM | S. horneri | Antioxidant | In vitro | H2O2-induced toxicity in SH-SY5Y cells and in primary cerebellar granule neurons (parameters assessed: cell viability, apoptosis, intracellular ROS, and signalling pathways activation) | [344] |